Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (221-230 of 494) with videos related to

Pageof 50
Sort By:
Oncotarget|April 8, 2020
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinomaFrank Jacobsen, Jacob Kohsar, Florian Gebauer, et al.
Pathology, Research and Practice|June 25, 2021
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancerSebastian Dwertmann Rico, Barbara Schmalfeldt, Volkmar Müller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 26, 2014
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancerAntje Krohn, Fabian Freudenthaler, Silvia Harasimowicz, et al.
Oncology Letters|March 19, 2019
p53 overexpression is a prognosticator of poor outcome in esophageal cancerNathaniel Melling, Sonja Norrenbrock, Martina Kluth, et al.
Journal of Applied Genetics|December 21, 2011
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neckSylvia Hartmann, Marcin Szaumkessel, Itziar Salaverria, et al.
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Urologic Oncology|October 17, 2018
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinomaFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Scientific Reports|December 5, 2018
Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate CancerTobias Lange, Su Jung Oh-Hohenhorst, Simon A Joosse, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Pageof 50

Showing results (221-230 of 494) with videos related to

Sort By:
Pageof 50
Oncotarget|April 8, 2020
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinomaFrank Jacobsen, Jacob Kohsar, Florian Gebauer, et al.
Pathology, Research and Practice|June 25, 2021
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancerSebastian Dwertmann Rico, Barbara Schmalfeldt, Volkmar Müller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 26, 2014
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancerAntje Krohn, Fabian Freudenthaler, Silvia Harasimowicz, et al.
Oncology Letters|March 19, 2019
p53 overexpression is a prognosticator of poor outcome in esophageal cancerNathaniel Melling, Sonja Norrenbrock, Martina Kluth, et al.
Journal of Applied Genetics|December 21, 2011
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neckSylvia Hartmann, Marcin Szaumkessel, Itziar Salaverria, et al.
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Urologic Oncology|October 17, 2018
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinomaFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Scientific Reports|December 5, 2018
Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate CancerTobias Lange, Su Jung Oh-Hohenhorst, Simon A Joosse, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Pageof 50